Aminoglikozid — разлика између измена

Brojni aminoglikozidi delujz kao [[antibiotik|antibiotici]]. Među njima su [[amikacin]], [[arbekacin]], [[gentamicin]], [[kanamicin]], [[neomicin]], [[netilmicin]], [[paromomicin]], rodostreptomicin,<ref>{{cite press release | title = Bacterial 'battle for survival' leads to new antibiotic | publisher = Massachusetts Institute of Technology | date = 26. 2. 2008. | url = http://web.mit.edu/newsoffice/2008/antibiotics-0226.html | accessdate = 1. 12. 2010. |archive-url=https://web.archive.org/web/20121026075119/http://web.mit.edu/newsoffice/2008/antibiotics-0226.html |archive-date = 26. 10. 2012 |dead-url=yes |df=}}</ref> [[streptomicin]], [[tobramicin]], i [[apramicin]]<ref>{{cite journal| last = Ryden| first = R |last2=Moore| author2first2 = Moore BJB. J.| title = . | journal = J Antimicrob Chemother| year = 1977| volume = 3| issue = 6| pages = 609–613}}</ref>.

Aminoglikozidi koji koji su izvedeni iz bakterija -{''[[Streptomyces]]''}- [[rod (biologija)|roda]] i oni koji su izvedeni iz -{''[[Micromonospora]]}-''<ref>{{cite journal | vauthors = Kroppenstedt RM, Mayilraj S, Wink JM | title = Eight new species of the genus Micromonospora, Micromonospora citrea sp. nov., Micromonospora echinaurantiaca sp. nov., Micromonospora echinofusca sp. nov. Micromonospora fulviviridis sp. nov., Micromonospora inyonensis sp. nov., Micromonospora peucetia sp. nov., Micromonospora sagamiensis sp. nov., and Micromonospora viridifaciens sp. nov | journal = Syst Appl Microbiol. | volume = 28 | issue = 4 | pagesyear = 328–39 | year=2005 | pmid = 15997706|pages=328–39}}</ref> imaju sufiks ''-micin''.<ref>{{Cite book | title = Medicinal Natural Products: A Biosynthetic Approach | last = Dewick| first = Paul M.| publisher = Wiley | edition = 3rd ed | year =2009 2009| isbn = 978-0-470-74167-2| pages = }}</ref>

Ovaj sistem nomenklature nije specifičan za aminoglikozide. Na primer, [[vankomicin]]<ref>{{cite journal | journal = Antimicrob Agents Chemother | year =1974 1974| volume = 6 | issue = 6 | pages = 722–728 | pmc = 444726 | title = On the Mechanism of Action of Vancomycin: Inhibition of Peptidoglycan Synthesis in Gaffkya homari | author last=Hammes1|first= Walter P. Hammes1 and Francis C. Neuhaus|pages=722–728}}</ref> je [[glikopeptidni antibiotik]], kao i [[eritromicin]], koji se dobija od vrste -{''[[Saccharopolyspora erythraea]]''}- (ranije misklasifikovane kao -{''[[Streptomyces]]''}-) zajedno sa njegovim sintetičkim derivatima [[klaritromicin]]om i [[azitromicin]]om, je [[makrolid]].<ref name=pharmamotion>[http://pharmamotion.com.ar/protein-synthesis-inhibitors-macrolides-mechanism-of-action-animation-classification-of-agents/ Protein synthesis inhibitors: macrolides mechanism of action animation. Classification of agents] {{Wayback| url = http://pharmamotion.com.ar/protein-synthesis-inhibitors-macrolides-mechanism-of-action-animation-classification-of-agents/ | date = 20081226204524 }} Pharmamotion. Author: Gary Kaiser. The Community College of Baltimore County. Retrieved on July 31, 2009</ref><ref name=lovmar>[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WK7-490R2TT-C&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=19d53b7156b390f5ed0a09eb156c18ea The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome] Martin Lovmar and Måns Ehrenberg</ref>

* {{Cite book | ref = harv | ref = harv| title = Medicinal Natural Products: A Biosynthetic Approach | last = Dewick| first = Paul M.| publisher = Wiley | edition = 3rd | year =2009 2009|isbn=978-0-470-74167-2}}